Dynamic Congruence Total Knee Replacement vs Posterior-stabilized (K-Mod)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04524312 |
|
Recruitment Status :
Completed
First Posted : August 24, 2020
Last Update Posted : September 29, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Osteo Arthritis Knee Surgery Joint Diseases | Procedure: Total knee replacement Diagnostic Test: Biomechanics Device: NexGen Ps or Bioimplanti K-MOD implant | Not Applicable |
The aim of this study is to assess and compare kinematic and time-space gait parameters in patients after total knee arthroplasty, who will undergo the surgery with the use of either posterior-stabilized (PS) or dynamic congruence (DC) implants.
Materials and methods To this study 56 consecutive patients undergoing total knee arthroplasty will be recruited. Study protocol is designed as a prospective, blinded, parallel-group, superiority trial, with balanced randomization [1:1]. All participants will be operated in single clinical orthopedic department, by single high-volume surgeon, who performed more than 3000 total knee arthroplasties in his professional career.
Before the surgery patients will fulfill the author's questionnaire concerning their age, height and body mass, level of activity and VAS (Visual Analogue Scale).
After the surgery 1 to 3 years postoperatively three-dimensional gait analysis will performed with use of BTS SMART device. This device uses passive markers technology and registers the movement by six cameras. To perform full gait analysis several data concerning patients anthropometry will be collected (lower limb length, knee and ankle joint width, width and depth of the pelvis). Whole gait analysis will be performed by experienced single clinical biomechanist accordingly to the Davis protocol. Markers will be installed on the patients' limbs on the following points: base of sacral bone, greater trochanter of the femur, lateral femoral condyle, head of the fibula, lateral malleoli, head of the V metatarsal bone).
Participants will walk barefoot for 10 meters quadruple times. Following time-space and kinematic parameters will be assessed:
Time-space parameters Single stance time (T1) [%] Swing time (T2) [%] Double-stance time (T3) [%] Step length (SL) [m] Mean gait velocity (Vm) [m/s] Cadence (C) [number of steps/min]
Kinematic parameters:
Operated knee range of flexion during swing phase [°]
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 56 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Masking Description: | Participant will not be informed which type of prosthesis was used in their particular case. Outcomes Assessor will not be informed which type of prosthesis was used in particular patient. |
| Primary Purpose: | Treatment |
| Official Title: | Does Dynamic Congruence Design Improve Gait After Total Knee Replacement in Comparison to Posterior-stabilized One? - Prospective Randomized Controlled Trial |
| Actual Study Start Date : | December 1, 2017 |
| Actual Primary Completion Date : | September 26, 2020 |
| Actual Study Completion Date : | September 26, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: NexGen
Patients undergoing total knee replacement for treatment of primary knee ostearthritis with use of Zimmer Biomet NexGen prosthesis
|
Procedure: Total knee replacement
Participant will undergo total knee replacement performed via anterior parapatellar approach with either Posterior-stabilized or retaining cruciate-retaining with dynamic congruence implant Diagnostic Test: Biomechanics Participants will be asked to perform biomechanical assesment before and following surgery at baseline, 6-8 weeks and 6-months postoperatively Device: NexGen Ps or Bioimplanti K-MOD implant Participant are randomly allocated to receive one of the NexGen PS or Biomplanti K-MOD total knee implant for treatment of end-stage knee osteoarthritis. |
|
Active Comparator: K-Mod
Patients undergoing total knee replacement for treatment of primary knee ostearthritis with use of Bioimplanti K-MOD prosthesis
|
Procedure: Total knee replacement
Participant will undergo total knee replacement performed via anterior parapatellar approach with either Posterior-stabilized or retaining cruciate-retaining with dynamic congruence implant Diagnostic Test: Biomechanics Participants will be asked to perform biomechanical assesment before and following surgery at baseline, 6-8 weeks and 6-months postoperatively Device: NexGen Ps or Bioimplanti K-MOD implant Participant are randomly allocated to receive one of the NexGen PS or Biomplanti K-MOD total knee implant for treatment of end-stage knee osteoarthritis. |
- Time of swing phase [ Time Frame: Time Frame: 1-3 years after surgery ]
Change from baseline part of swing phase time during gait, measured in percentage
Change from baseline part of swing phase time during gait, measured in percentage
- Time of stance phase [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline part of stance phase time during gait, measured in percentage
- Time of double-stance phase [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline part of double-stance phase time during gait, measured in percentage
- Stride length [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline length of stride during gait, measured in meters
- Cadence [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline number of strides per minute of walking
- Mean gait velocity [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline mean values of gait speed, measured in meters per second
- Range of maximal hip extension for both limbs during ending part of mid-stance phase [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline range of maximal hip extension for both limbs during ending part of mid-stance phase, measured in degrees
- Range of pelvic drop in frontal plane on the opposite site of the bearing limb [ Time Frame: Time Frame: 1-3 years after surgery ]Change from baseline range of pelvic drop in frontal plane on the opposite site of the bearing limb, measured in degrees
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- agreement to participate in the study
- BMI (kg/m2) less than 40
- ability to walk for 10 meters
- knee flexion more or equal of 90 degrees
Exclusion Criteria:
- unwillingness to participate in the study
- osteoarthritis due to the rheumatological disease
- disorders associated with nerve-muscle signal transmission
- neurological disorders associated with dizziness, nystagmus or other conditions that might influence balance during activity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04524312
| Poland | |
| Department of Othopedics and Rehabilitation, Medical University of Warsaw | |
| Warszawa, Mazowieckie, Poland, 03-984 | |
| Principal Investigator: | Bartosz M. Maciąg, MD | Medical University of Warsaw |
| Responsible Party: | Artur Stolarczyk, MD, PhD, Medical University of Warsaw |
| ClinicalTrials.gov Identifier: | NCT04524312 |
| Other Study ID Numbers: |
WarsawMU/kmod |
| First Posted: | August 24, 2020 Key Record Dates |
| Last Update Posted: | September 29, 2020 |
| Last Verified: | September 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
osteoarthritis knee congruence posterior-stabilized cruciate-retaining |
|
Joint Diseases Osteoarthritis Osteoarthritis, Knee |
Arthritis Musculoskeletal Diseases Rheumatic Diseases |

